Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

High doses of fluconazole can cause reversible hair loss.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hypothyroidism may cause certain types of hair loss.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that individualized reconstruction plans are essential for improving function and appearance after head and neck burns.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The shape and size of the placenta may help predict future health risks for both mother and child.

Researchers developed a new, precise method to measure hair loss in mice using image analysis.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

Finasteride increases hair weight and count in men with hair loss.